Shuttle Pharma asks shareholders to approve massively dilutive merger-related issuances and pivot to Dogecoin mining
SHPH sits 32% above its 52-week low of $2.576 on light trading volume (0.1× avg).
Summary
Shuttle Pharmaceuticals seeks shareholder approval for the issuance of up to ~17.6 million shares related to its merger with United Dogecoin and a PIPE financing, along with an equity plan increase to 8.8 million shares and a name change to United Compute Inc. The proposals would massively dilute existing holders but are necessary to fund the company's pivot to Dogecoin mining.
Key Events · Corporate Governance and Compliance · SHPH
-
Massive Dilution from Merger and PIPE
Proposal 1 seeks approval for up to ~3.8M shares from Series B-1 Preferred Stock conversion and ~13.8M shares from pre-funded warrants under the Merger Agreement. Proposal 2 seeks approval for up to ~927K shares from Series B-2 Preferred Stock conversion, ~927K shares from common warrants, and ~3.1M shares from pre-funded warrants under the Securities Purchase Agreement. Combined, these represent a potential ~27x increase over the current ~637K outstanding shares.
-
Equity Plan Increase to 8.8M Shares
Proposal 3 seeks to increase the 2018 Equity Incentive Plan share reserve from 800,000 to 8,800,000 shares, a 10x increase, to support hiring and retention following the merger.
-
Name Change to United Compute Inc.
Proposal 4 seeks to rename the company to United Compute Inc., reflecting the pivot from pharmaceuticals to Dogecoin mining and high-performance computing.
-
Co-CEO's Substantial Interest
Co-CEO Ryan Trasolini, founder of United Dogecoin, would beneficially own ~11.4% of the company upon full conversion and exercise of his Series B-1 Preferred Stock and pre-funded warrants, creating a significant governance concentration.
Analysis · SHPH · Life Sciences
Shuttle Pharmaceuticals is asking shareholders to approve the issuance of up to ~17.6 million shares tied to its merger with United Dogecoin and a concurrent PIPE financing — a move that would increase the outstanding share count by roughly 27x based on the current ~637,000 shares. The proxy also seeks to boost the equity plan reserve to 8.8 million shares and rename the company to United Compute Inc., cementing its pivot from biotech to Dogecoin mining. Co-CEO Ryan Trasolini stands to control ~11.4% of the company if all conversions and warrants are exercised, creating a significant governance overhang. The company has no revenue, a going concern warning, and material weaknesses in internal controls — this vote is effectively a referendum on whether the company can fund its new crypto-mining strategy without crushing existing shareholders.
At the time of this filing, SHPH was trading at $3.39 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $2.1M. The 52-week trading range was $2.58 to $55.90. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.